Close
ACHEMA MIDDLE EAST 2026
LogiPharma 2026

Drug Development

      US FDA Approves Breast Cancer Therapy Inluriyo by Eli Lilly

      Clinical Trials
      Eli Lilly and Company has received U.S. Food and Drug Administration (FDA) approval for Inluriyo (imlunestrant, 200 mg tablets), an oral estrogen receptor antagonist....

      Green Chemistry in Sustainable API Manufacturing

      Insights
      Green Chemistry Driving Sustainable API and Ingredient Production The pharmaceutical industry is at the cusp of a sustainability revolution, with green chemistry principles guiding the...

      Future of Active Pharmaceutical Ingredients Supply

      Drug Development
      The Future of Active Pharmaceutical Ingredients in Global Supply Chains Globalization has fundamentally transformed the ways in which pharmaceutical companies source and manufacture active pharmaceutical...

      Advances in Pharmaceutical Excipients for New Therapies

      Drug Development
      Advances in Pharmaceutical Excipients Supporting Next-Gen Therapies Pharmaceutical excipients, once deemed inert carriers, have evolved into active enablers that significantly influence drug stability, delivery, and...

      Innovative Ingredient Sourcing in Pharma Markets

      Insights
      Innovative Ingredient Sourcing Strategies in a Diversified Market In an era defined by supply chain vulnerabilities and shifting geopolitical landscapes, pharmaceutical companies are reimagining ingredient...

      Lilly to Build $6.5B API Manufacturing Facility in Houston

      Americas
      Eli Lilly and Company has unveiled plans for a $6.5 billion manufacturing facility in Generation Park, Houston, Texas. The project, described as a next-generation...

      US FDA to Approve Leucovorin for Cerebral Folate Deficiency

      Drug Development
      The U.S. Food and Drug Administration (FDA) has started the process to approve leucovorin calcium tablets as a treatment for patients with cerebral folate...

      Subscribe Our Newsletter

      White Papers

      The Future of Digital Health

      Whitepapers 0
      The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

      Five Best Practices to Deliver Exceptional Multichannel Experiences

      Whitepapers 0
      A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

      The Impact and Use of Social Media in Pharmacovigilance

      Whitepapers 0
      Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...

      About us

      Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

      System

      Resources

      Subscribe

      Copyright © Value Media Group 2026. All rights reserved.